Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595503 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01595503: Clinical Trial NA study, sponsored by University of Michigan.
NCT01595503 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01595503, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Repetitive transcranial magnetic stimulation (rTMS) is a new noninvasive therapy that uses magnetic energy applied to the scalp to modulate activity in the underlying regions of the brain. In this study we will examine the efficacy of treating auditory hallucinations in schizophrenia with rTMS, comparing two methods to target stimulation to a language processing region of the brain. One method targets the stimulation site using scalp landmarks, while the other uses functional magnetic resonance imaging (fMRI) combined with a language task.
Primary Outcome
Hallucination Change Scale (Hoffman RE, Gueorguieva R, Hawkins KA, Varanko M, Boutros NN, Wu YT, et al. (2005): Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 58:97-104.) Baseline score, by definition: 10 Range: 0 (no hallucinations) to 20 (hallucinations twice as bad as baseline) Thus, a score of less than 10 means that hallucinations were reduced, whereas a score of greater than 10 means
Interventions
- PROCEDURE rTMS with fMRI-based targeting
- PROCEDURE rTMS with landmark-based targeting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
| Phase | NA |
Why NCT01595503 stopped before completion
NCT01595503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which rTMS with fMRI-based targeting is the first listed.
NCT01595503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01595503 about?
NCT01595503 is a clinical study titled "Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia". Repetitive transcranial magnetic stimulation (rTMS) is a new noninvasive therapy that uses magnetic energy applied to the scalp to modulate activity in the underlying regions of the brain. In this study we will examine the efficacy of treating auditory hallucinations in schizophrenia with rTMS, comp...
What is the current status of trial NCT01595503?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2011-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01595503?
The interventions under investigation include: rTMS with fMRI-based targeting (PROCEDURE), rTMS with landmark-based targeting (PROCEDURE).
Who is sponsoring clinical trial NCT01595503?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01595503's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia